Researchers have found a number of previously unidentified genes that may act as drivers of prostate cancer. A new study found some mutations that are already targeted by approved or investigational drugs, along with dozens of targets that should be considered as candidates for future trials.
Whole-Genome Analyses Expand Genetic Picture of Prostate Cancer
source: Cancer Network